The observed changes in VE-cadherin expression following stroke may be regulated by sphingosine kinase (SphK2), as SphK2-null mice display reduced levels of VE-cadherin and other junctional proteins (Wacker et al., 2012). The gene discussed is CDH5; the disease is stroke disorder.